19 June 2013
Keywords: cypher, stent, superior, bs, taxus, health, care
Article | 14 March 2005
US health care giant Johnson & Johnson has been unable to demonstrate in a clinical trial that its Cypher sirolimus-eluting coronary ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
14 March 2005
7 March 2005
18 June 2013
© 2013 thepharmaletter.com